Industry News
Pharmaceutical Industry News
Eli Lilly’s Olympics campaign rewind: Leverage pandemic’s focus on health to assert its brand and assert its point of view
Eli Lilly's Olympics campaign rewind: Leverage pandemic's focus on health to assert its brand and assert its point of view bbulik Fri, 10/01/2021 - 14:01
Agile Therapeutics scores soccer superstar Carli Lloyd to help build its women’s health brand
Agile Therapeutics scores soccer superstar Carli Lloyd to help build its women's health brand nmissakian Fri, 10/01/2021 - 13:14
Is the cancer immunotherapy market up for disruption as AstraZeneca, Regeneron-Sanofi, cheaper Chinese offerings line up?
Is the cancer immunotherapy market up for disruption as AstraZeneca, Regeneron-Sanofi, cheaper Chinese offerings line up? aliu Fri, 10/01/2021 - 11:18
U.S. appeals court sides with Catalyst, calling FDA approval of Jacobus’ Ruzurgi ‘arbitrary,’ ‘capricious’ and unlawful
U.S. appeals court sides with Catalyst, calling FDA approval of Jacobus' Ruzurgi 'arbitrary,' 'capricious' and unlawful kdunleavy Fri, 10/01/2021 - 11:16
Fierce Pharma Asia—Biogen-Eisai’s Alzheimer’s drug filing; Samsung-Roche deal growth; Sunovion-Otsuka neuro pact
Fierce Pharma Asia—Biogen-Eisai's Alzheimer's drug filing; Samsung-Roche deal growth; Sunovion-Otsuka neuro pact aliu Fri, 10/01/2021 - 09:16
Moderna report says ‘human error’ to blame for contamination found in 3 vaccine lots from Rovi plant
Moderna report says 'human error' to blame for contamination found in 3 vaccine lots from Rovi plant kdunleavy Fri, 10/01/2021 - 08:37
Trouble builds for Merck’s $11.5B Acceleron buy as activist investor behind Gilead’s Immunomedics deal says too early, too cheap
Trouble builds for Merck's $11.5B Acceleron buy as activist investor behind Gilead's Immunomedics deal says too early, too cheap aliu Fri, 10/01/2021 - 06:07
Roche, Takeda and Pfizer notch top scores among rare disease patient advocacy groups
Roche, Takeda and Pfizer notch top scores among rare disease patient advocacy groups nmissakian Thu, 09/30/2021 - 11:39
La desinformación sobre la covid genera la escasez de ivermectina, un medicamento para animales
El mundo agropecuario lucha contra la creciente demanda de ivermectina, un medicamento antiparasitario que las redes de desinformación aseguran, sin pruebas, que ayuda contra el coronavirus.
Insider trading on 2 M&A deals made former Goldman Sachs compliance officer more than $77K, SEC charges
Insider trading on 2 M&A deals made former Goldman Sachs compliance officer more than $77K, SEC charges kdunleavy Thu, 09/30/2021 - 11:35
Fujifilm completes construction of Netherlands production facility, enters validation stage
Fujifilm completes construction of Netherlands production facility, enters validation stage jkeenan Thu, 09/30/2021 - 09:58
Fujifilm Irvine Scientific completes construction of Netherlands production facility, enters validation stage
Fujifilm Irvine Scientific completes construction of Netherlands production facility, enters validation stage jkeenan Thu, 09/30/2021 - 09:58
Merck CEO downplays PAH drug’s antitrust threat as it wades deeper into cardiovascular disease with $11.5B Acceleron buy
Merck CEO downplays PAH drug's antitrust threat as it wades deeper into cardiovascular disease with $11.5B Acceleron buy aliu Thu, 09/30/2021 - 09:46
Takeda, JCR ink deal to commercialize Hunter syndrome drug in key markets
Takeda, JCR ink deal to commercialize Hunter syndrome drug in key markets kdunleavy Thu, 09/30/2021 - 09:34
MannKind raises $102M in sale-leaseback of manufacturing plant to fund operations
MannKind raises $102M in sale-leaseback of manufacturing plant to fund operations jkeenan Thu, 09/30/2021 - 08:57
Regeneron’s COVID-19 antibody cocktail pads case for saving lives in hospitalized patients as FDA decision nears
Regeneron's COVID-19 antibody cocktail pads case for saving lives in hospitalized patients as FDA decision nears aliu Thu, 09/30/2021 - 05:09
Fierce Pharma awards best-in-class marketing campaigns in 3rd annual contest—and first live event
Fierce Pharma awards best-in-class marketing campaigns in 3rd annual contest—and first live event bbulik Wed, 09/29/2021 - 23:37
Pharma’s ‘painful’ social media start morphs into refined content strategies across even hipster channels: experts
Pharma's 'painful' social media start morphs into refined content strategies across even hipster channels: experts bbulik Wed, 09/29/2021 - 17:59
Mirum gets iBAT inhibitor Livmarli across the FDA finish line for rare pediatric liver condition
Mirum gets iBAT inhibitor Livmarli across the FDA finish line for rare pediatric liver condition kdunleavy Wed, 09/29/2021 - 15:30
Despite rough start, Biogen’s Aduhelm should find footing, analysts say. But don’t expect much in 2021
Despite rough start, Biogen's Aduhelm should find footing, analysts say. But don't expect much in 2021 esagonowsky Wed, 09/29/2021 - 13:54